Fibromyalgia — Efficacy and Safety of an Oral Growth Hormone Drug in the Treatment of Fibromyalgia
Citation(s)
A Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Safety and Efficacy of MK-0677 25 mg in the Treatment of Primary Fibromyalgia